Oncology RSS Feeds

Directory1 oncology feeds · 14 articlesEnglish only →

Latest

Oncology articles

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins inside cells and mark them for destruction. Despite initial skepticism, this approach led to a breakthrough drug for pancreatic cancer deve

Newssciencehealthbiotechnology

pasadenastarnews.com·Tech by Flipboard·49m ago·7 min read

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Newssciencehealthmedical research

Shared by @sallyb33755.bsky.social on Bluesky ↗

npr.org2h ago

Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial

Newssciencehealthmedical breakthrough

Shared by @tsitsilagi.bsky.social on Bluesky ↗

cnbc.com3h ago

Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows

Newssciencehealthmedical breakthrough

theguardian.com4h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients

Newssciencehealthmedical breakthrough

Shared by @chicagotribune.com on Bluesky ↗

chicagotribune.com5h ago

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

Newssciencehealthmedical research

Shared by @davidbflower.bsky.social on Bluesky ↗

bbc.co.uk1d ago

Principles and guidance for developing lncRNA-targeted cancer therapies

Insightsciencehealthoncology

Shared by @shihcheng.bsky.social on Bluesky ↗

doi.org1d ago

Molecular glue drugs show promise as breakthrough pancreatic cancer treatment, driving industry dealmaking

Chemical biologist Gregory Verdine pioneered the concept of "molecular glues" — drugs that bind to disease-causing proteins inside cells and mark them for destruction. Despite initial skepticism, Revolution Medicines Inc. (which acquired one of Verdine's companies in 2018) has ac

Newshealthbiotechnologybusiness

mercurynews.com·Tech by Flipboard·1d ago·7 min read

Dose-reduced thoracic radiotherapy shows promise for older and frail stage III NSCLC patients in randomized trial

This randomized open-label cohort trial by Wei-Xiang Qi and colleagues investigates whether dose-reduced thoracic radiotherapy can mitigate treatment-related toxicities while preserving oncological outcomes in older and/or frail patients with Stage III non-small-cell lung cancer

Insightsciencehealthoncology

plos.io·Science·3d ago·32 min read

EU-funded Czech cancer prevention centre in Brno leverages AI and early detection to tackle Europe's growing oncology burden

Czechia has opened a major new cancer prevention centre in Brno, the Centre for Oncological Prevention at the Masaryk Memorial Cancer Institute (MOÚ), as part of a €46.1 million modernisation project largely funded by the EU's NextGenerationEU. The centre focuses on earlier detec

Newstechnologyhealtheu policy

dlvr.it·Tech by Flipboard·3d ago·4 min read

HistoSonics develops ultrasound-based histotripsy to destroy cancer tumors without surgery

Newstechnologyhealthmedical technology

Shared by @awi-bu.bsky.social on Bluesky ↗

flip.it4d ago

UC San Diego AI Model Predicts Cancer Treatment Response from Tumor Genetics

Newssciencehealthartificial intelligence

Shared by @gbgrizzoh.bsky.social on Bluesky ↗

today.ucsd.edu4d ago

Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment

Newssciencehealthmedical research

nypost.com3mo ago

Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients

Newssciencehealthmedical research

today.ucsd.edu6mo ago

CancerNetwork1

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial

Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

Principles and guidance for developing lncRNA-targeted cancer therapies

Molecular glue drugs show promise as breakthrough pancreatic cancer treatment, driving industry dealmaking

Dose-reduced thoracic radiotherapy shows promise for older and frail stage III NSCLC patients in randomized trial

EU-funded Czech cancer prevention centre in Brno leverages AI and early detection to tackle Europe's growing oncology burden

HistoSonics develops ultrasound-based histotripsy to destroy cancer tumors without surgery

UC San Diego AI Model Predicts Cancer Treatment Response from Tumor Genetics

Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment

Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients